Indian Immunologicals Limited (IIL) has signed an MoU with INTA and Littoral Biologics of Argentina for transfer of technology for Bovine Parasitic vaccines in India. Introduction of vaccines against haemoprotozoan infections transmitted by ticks such as Babesiosis and Anaplasmosis will prevent loss in productivity in cattle and immensely benefit dairy farmers.
Instituto Nacional de Tecnologia Agropecuaria (INTA), Argentina is Argentinian federal agency in charge of the generation, adaptation and diffusion of technologies.
“Economic losses due to Babesisosis alone in India are estimated to be about US$ 57.2 million”, said Dr K Anand Kumar, Managing Director, Indian Immunologicals Limited.
“IIL is only vaccine manufacturer in India which is capable of producing effective parasitic vaccines for animals with vast experience in producing vaccine against haemoprotozoan Theileria annulata, since three decades. We recently introduced a vaccine against Porcine Cysticercosis, a parasitic vaccine for pigs. This agreement with the Argentinean collaborators will go a long way in uplifting productivity among dairy farmers in India,” he added.
Dr Manual G Garcia, Director General of Littoral, Dr Nicora Amadeo, President INTA, Dr Cerioni Adolfo Luis, National Coordinator, INTA, Argentina signed the agreement with Indian Immunologicals to transfer technology to produce vaccine against Babesiosis and Anaplasmosis. IIL’s Rakshavac-T which is a vaccine against Theileria annulata is the only vaccine against haemoprotozoan infections in India.
IIL is set to address this unmet need to control haemoprotozoan diseases transmitted by ticks in India and prevent loss of productivity in cattle.
Indian Immunologicals Limited (IIL) is a wholly owned subsidiary of the National Dairy Development Board (NDDB). It operates the largest vaccine manufacturer in Asia. Besides being largest manufacturer of Foot and Mouth Disease (FMD) vaccine in the world, IIL manufactures most of the livestock vaccines for Bovines, Canines, Sheep, Goats, Pigs etc. It is also the leading human vaccine manufacturer, producing several vaccines for adults and children. Human Anti-rabies vaccine Abhayrab is the largest brand in Indian market.